During the trial , the mean percentage of urine samples negative for opioids was lower for patients in the taper group ( 35.2 % [ 95 % CI , 26.2 % -44.2 % ] ) compared with those in the maintenance group ( 53.2 % [ 95 % CI , 44.3 % -62.0 % ] ) .